newsfilter
← Latest News
PR Newswire·

NeuroBo Pharmaceuticals Announces 1-for-8 Reverse Stock Split

NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on the transformation of cardiometabolic diseases, today ...